This former Russian military secret is now available to the public!
Today Professor Vladimir Khavinson is the President of the European Academy of Gerontology and Geriatrics,
but in the 1980’s he was a Colonel in the Soviet Union military medical
corps. At the time, he and his team were approached by Kremlin
officials, they wanted them to find a way to protect their troops from a
myriad of problems; issues such as radiation for submariners in nuclear
submarines to troops that may be blinded from known, (but thankfully
unused) new weapons such as battlefield lasers.
What their secret research uncovered- that was used for two decades
on many thousands of men and women- was a remarkable link between short
chain peptides and DNA.
Now their published research is in the open and it identifies that
each organ/ gland/ tissue uses a highly specific short chain peptide to
act as a ‘short cut’ to initiate protein synthesis. These peptides can
be found in food and unlike proteins they can enter the blood through
the stomach. Through a comprehensive list of patents and even
copyrighted PowerPoint slides, the Russian research group are showing
that each of the concentrated peptide bioregulators so far examined
interact with particular strands of DNA- effectively and very
specifically activating repair and regenerative processes.
This is a remarkable story since what we are describing here are
individualised gene switches and since they have been tested for many
years on thousands of individuals, without report of any serious side
effects or contraindications to date, they could be set to ‘out do’ stem
cells. Why? Because this peptide therapy is relatively cheap, highly
specific, can be taken orally and doesn’t require any suppression of the
immune system to operate fully.
Professor Khavinson and his award winning team at the St Petersburg Institute of Biogerontology
have discovered that each organ/ gland has a biological reserve and
despite the origin of the tissue they have studied, incredibly each one
is always set at 42%
Even dosing doesn’t need to be daily, these peptide bioregulators
have been shown to act even after a simple course of 2 capsules daily
for 10-days. Healthy individuals only being encouraged to repeat the
course 6-months later, although of course depending on the need this
course can be repeated every 3-months, 2-months or 1-month if necessary.
But compared to a hormone replacement therapy this is interesting,
since hormones would require almost daily application. But these peptide
bioregulators aren’t hormones, they are acting on the gland concerned
to ‘encourage’ it to become active and effectively ‘younger’ by
triggering/ activating the DNA responsible.
Here at IAS we are excited about this emerging technology and have
been following it since 2010 and will be reporting much more, though
articles, interviews and videos etc., so please stay tuned. There’s more
to learn including the synergistic interaction of the peptide
bioregulators themselves and if individuals are using hormones
concurrently, then there may well be a need to monitor their blood
levels more closely with a view to lowering those doses and applications
Note: Of the 20 or so peptide bioregulators available IAS has chosen
the following, (and will be adding more into the range in due course). All the sources of these Peptide Bioregulators are from carefully chosen Danish bovine tissues and processed through pharmaceutical processes and filters.